Drugs or medicines for influencing the central nervous system

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2605011, 260563P, 424316, A01N 920, A01N 924

Patent

active

041221931

ABSTRACT:
Certain 1,3,5-trisubstituted adamantane compounds having central nervous system activity, especially anti-Parkinsonism activity, method of preparing same, and pharmaceutical compositions thereof, method of influencing the central nervous system therewith.

REFERENCES:
patent: 3391142 (1968-07-01), Mills et al.
patent: 3789073 (1974-01-01), Narayama et al.
patent: 3929888 (1975-12-01), Cashin et al.
Eberhard et al., "Chemical Abstracts," vol. 71, p. 235, Section No. 38444b (1969).
Wagner et al., "Synthetic Organic Chemistry," p. 664 (1953).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Drugs or medicines for influencing the central nervous system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drugs or medicines for influencing the central nervous system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs or medicines for influencing the central nervous system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2336630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.